ABBV Earnings
AbbVie Inc. next reports earnings on October 30, 2026. Track record: 3/4 beats.
Earnings Reported
October 30, 2026
Current Price
$294.89
EPS Estimate
Earnings Per Share
$3.89
+43.4% YoY
Trailing EPS
Last 12 months earnings
$3.54
Beat Rate
3/4
75%Forward P/E
Price-to-Earnings ratio
18.2
Margin: 9.8%
Analyst Rating
27 analysts
Analyst Sentiment
Buy27 analystsTrading above average target while rated "Buy." Price may have rallied faster than analysts updated targets.
Earnings History
| Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| 2026-09-30 | $3.77 | $3.82 | +1.3% | Beat |
| 2026-06-30 | $3.61 | $3.65 | +1.1% | Beat |
| 2026-03-31 | $2.67 | $2.65 | -0.8% | Miss |
| 2025-12-31 | $2.65 | $2.71 | +2.2% | Beat |
Growth Estimates
| Period | EPS Est. | Revenue Est. | Growth |
|---|---|---|---|
| Current Qtr(0q) | $3.89 | $18.3B | +43.4% |
| Next Qtr(+1q) | $3.33 | $16.3B | +25.7% |
| Current Year(0y) | $13.95 | $67.6B | +39.5% |
| Next Year(+1y) | $16.20 | $73.5B | +16.1% |
Next Quarter Estimates
EPS Estimate
Earnings Per Share
$3.89
Revenue Estimate
$18.3B
Annual EPS Est.
$13.95
+39.5% YoY
ABBV Earnings FAQ
When is ABBV's next earnings date?
AbbVie Inc. (ABBV) is expected to report earnings on October 30, 2026. The consensus EPS estimate is $3.89.
Does ABBV usually beat earnings estimates?
AbbVie Inc. has beaten Wall Street EPS estimates in 3 of the last 4 quarters (75% beat rate).
What is ABBV's trailing EPS?
AbbVie Inc.'s trailing twelve-month EPS is $3.54. This is calculated from the last four quarters of reported earnings.
What do analysts think about ABBV?
27 Wall Street analysts cover AbbVie Inc.. The consensus rating is "Buy" with an average price target of $283.19, implying 4.0% downside from the current price.